Will Cortexyme Inc (CRTX) Beat the Rest of the Stocks in the Healthcare Sector?

Friday, July 01, 2022 11:50 AM | InvestorsObserver Analysts

Mentioned in this article

Will Cortexyme Inc (CRTX) Beat the Rest of the Stocks in the Healthcare Sector?

Cortexyme Inc (CRTX) is near the top in its sector according to InvestorsObserver. CRTX gets an overall rating of 41. That means it scores higher than 41% of stocks. Cortexyme Inc gets a 70 rank in the Healthcare sector. Healthcare is number 3 out of 11 sectors.

CRTX has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on CRTX!

See Full CRTX Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Cortexyme Inc Stock Today?

Cortexyme Inc (CRTX) stock has risen 7.21% while the S&P 500 is down -0.08% as of 11:49 AM on Friday, Jul 1. CRTX has risen $0.16 from the previous closing price of $2.22 on volume of 238,449 shares. Over the past year the S&P 500 is down -12.44% while CRTX is down -95.68%. CRTX lost -$2.96 per share the over the last 12 months. Click Here to get the full Stock Report for Cortexyme Inc stock.